

Treadwell Therapeutics, a clinical-stage oncology company, has secured $27 million in seed funding. The investor was TIO Bioventures.
Source: Press Release
Treadwell Therapeutics, a clinical-stage oncology company, has secured $27 million in seed funding.
Treadwell Therapeutics, a clinical-stage oncology company, has secured $27 million in seed funding. The investor was TIO Bioventures.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination